Newsletter
Inside DO-IT: A Participant Shares Her Experience
Safety and Efficacy of Intravenous Thrombolysis
in Patients with Ischemic Stroke and Recent
Ingestion of Direct Oral Anticoagulants
Safety and Efficacy of Intravenous Thrombolysis
in Patients with Ischemic Stroke and Recent
Ingestion of Direct Oral Anticoagulants
tfernandez
Approval of Telerandomisation in Germany and Norway
DO-IT Newsletter (EU)
New protocol version coming into action
Celebrating Continued Progress in the DO-IT Trial
We are proud to share a major milestone in the DO-IT trial: the enrollment of patient 200, reached during ESOC—a fantastic achievement and a testament to the collective effort across all sites. A special recognition goes to the outstanding teams…
DO-IT Trial Newsletter
ESOC Meeting & Recruitment Milestones
100 Patients Randomized
Thank You and Key Reminders as We Move Forward
2025 Highlights and season’s Greetings from the DO-IT Core Team!
Merry Christmas and Happy new year!
🔊Exciting DO-IT Trial Update!🔊
Co-funding has been granted from the BHF for the UK, DHF for the Netherlands, PHRC-N for France, and Akershus University Hospital, internal open research funding for Norway.👏 A big thank you to David Werring, Jonathan Coutinho, Guillaume Turc, and Espen…
Newsletter 15.10.2025
! Next Milestone Achieved !First Patient Randomised in Europe(Amsterdam UMC)
Newsletter UK 27.08.2025
!! EXCITING NEWS !!Major Progress in the DO-IT trial: RegulatoryApprovals, Site Activation and UK Launch